Jerry Avorn
Harvard University
H-index: 148
North America-United States
Top articles of Jerry Avorn
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Patient characteristics associated with using transcatheter left atrial appendage occlusion versus oral anticoagulants for atrial fibrillation | Circulation: Cardiovascular Quality and Outcomes | Kueiyu Joshua Lin Daniel E Singer Jerry Avorn E Kevin Heist Sushama Kattinakere Sreedhara | 2024/3 |
Abstract PO4-10-12: Value of Molecular Targets and Genome-Targeted Therapies FDA-Approved for Metastatic Breast Cancer, 2006-2023 | Cancer Research | Ariadna Tibau Thomas J Hwang Consolacion Molto Valiente Jerry Avorn Aaron Kesselheim | 2024/5/2 |
Characteristics of Patients Receiving Novel Muscular Dystrophy Drugs in Trials vs Routine Care | JAMA Network Open | Dongzhe Hong Jerry Avorn Richard Wyss Aaron S Kesselheim | 2024/1/2 |
Abstract PO5-10-08: Clinical Value of Molecular Targets and Genome-Targeted Cancer Therapies Recommended by the National Comprehensive Cancer Network for Advanced Breast Cancer | Cancer Research | Ariadna Tibau Thomas J Hwang Jerry Avorn Aaron Kesselheim | 2024/5/2 |
March-In Guidance For Publicly Funded Drugs: A Necessary Safety Net For Patients | Health Affairs Forefront | Jerry Avorn Aaron S Kesselheim | 2024 |
Clinical Value of Molecular Targets and FDA-Approved Genome-Targeted Cancer Therapies | JAMA oncology | Ariadna Tibau Thomas J Hwang Consolacion Molto Jerry Avorn Aaron S Kesselheim | 2024/4/4 |
Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone–Salmeterol to Treat Chronic Obstructive Pulmonary Disease | Annals of Internal Medicine | William B Feldman Aaron S Kesselheim Jerry Avorn Massimiliano Russo Shirley V Wang | 2024/1 |
Use of efficiency frontiers to align prices and clinical benefits of biologic therapies for plaque psoriasis | JAMA dermatology | Alexander C Egilman Aaron S Kesselheim Jerry Avorn Adam JN Raymakers Benjamin N Rome | 2024/4/1 |
Potential Medicare and Medicaid Savings on Anti-CD20 Therapy for Multiple Sclerosis | JAMA neurology | John Kim Aaron S Kesselheim Riley Bove Jerry Avorn Benjamin N Rome | 2024/1/1 |
Pragmatic trial evaluating the impact of simulation training on high‐risk prescribing to older adults by junior physicians | Journal of the American Geriatrics Society | Julie C Lauffenburger Matthew F DiFrancesco Gauri Bhatkhande Katherine L Crum Erin Kim | 2024/3/8 |
Surrogate measures of drug efficacy—a finger pointing at the moon | JAMA Network Open | Jerry Avorn | 2023/4/3 |
1703P Value of molecular targets and genome-targeted cancer therapies FDA-approved, 2015-2022 | Annals of Oncology | A Tibau TJ Hwang M Consolacion J Avorn A Kesselheim | 2023/10/1 |
US public investment in development of mRNA covid-19 vaccines: retrospective cohort study | bmj | Hussain S Lalani Sarosh Nagar Ameet Sarpatwari Rachel E Barenie Jerry Avorn | 2023/3/1 |
The regulatory repercussions of approving muscular dystrophy medications on the basis of limited evidence | Liam Bendicksen Diana M Zuckerman Jerry Avorn Sophia Phillips Aaron S Kesselheim | 2023/9 | |
Sources of innovation in gene therapies-Approaches to achieving affordable prices | The New England journal of medicine | Kerstin N Vokinger Jerry Avorn Aaron S Kesselheim | 2023/1/26 |
Chronic obstructive pulmonary disease exacerbations and pneumonia hospitalizations among new users of combination maintenance inhalers | Jessica Spiteri Louise Grech Stephen Montefort Lilian M Azzopardi | 2018 | |
Variation in use of lung cancer targeted therapies across state Medicaid programs, 2020-2021 | JAMA Network Open | Thomas J Roberts Aaron S Kesselheim Jerry Avorn | 2023/1/3 |
Generic Vs. Brand-name Fluticasone-Salmeterol in the Prevention of COPD Exacerbations | WB Feldman A Kesselheim J Avorn S Wang | 2023/5 | |
Federal Funding For Discovery And Development Of Costly HIV Drugs Was Far More Than Previously Estimated: Study examines federal funding for discovery and development of costly … | Health Affairs | Frazer A Tessema Rachel E Barenie Jerry Avorn Aaron S Kesselheim | 2023/5/1 |
Wedding Websites, Free Speech, and Adverse Drug Effects | New England Journal of Medicine | Jerry Avorn | 2023/10/19 |
